Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-10

Clinical Trial Update: St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Gabapentin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating naltrexone and gabapentin for pain and alcohol use interventions completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: Boston Medical Center | Conditions: Chronic Pain, Alcohol Use, Unspecified | Phase 2 | Status: COMPLETED | Results posted: 2022-11-10